13 Nov 2022 , 09:00 AM
Net profit of Bharat Parenterals rose 24.78% to Rs 9.92 crore in the quarter ended September 2022 as against Rs 7.95 crore during the previous quarter ended September 2021. Sales rose 35.60% to Rs 81.90 crore in the quarter ended September 2022 as against Rs 60.40 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 81.90 | 60.40 | 36 |
| OPM % | 11.21 | 16.56 | – |
| PBDT | 15.25 | 12.36 | 23 |
| PBT | 13.79 | 10.64 | 30 |
| NP | 9.92 | 7.95 | 25 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
